ASSESSMENT OF SOFT TISSUE HEALING OVER IMMEDIATELY PLACED IMPLANT SEALED WITH PLATELETS RICH FIBRIN (PRF) VERSUS DIODE LASER
1 other identifier
interventional
16
1 country
1
Brief Summary
Aim of the current study was to assess the efficacy of PRF in comparison to diode laser to promote tissue healing and soft tissue quality after placement of immediate implants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedFirst Submitted
Initial submission to the registry
August 24, 2022
CompletedFirst Posted
Study publicly available on registry
August 26, 2022
CompletedAugust 26, 2022
August 1, 2022
1 year
August 24, 2022
August 24, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
Soft tissue healing
This was done using Landry healing index. It evaluates the parameters of tissue colour, bleeding response to palpation, presence of granulation tissue, characteristics of the incision margins, and the presence of suppuration. The score ranges from 1 (Very poor) to 5 (Excellent).
up to 4 weeks
Mid-buccal soft tissue thickness
Measured from the gingival margin to implant platform using a periodontal probe.
up to 8 weeks
Mid-crestal soft tissue height
Measured using a periodontal probe passing through soft tissue in the intersection midpoint of both buccolingual and mesiodistal dimensions of the socket till cover screw.
up to 8 weeks
Secondary Outcomes (1)
Post-operative pain level
24 hours
Study Arms (2)
Platelet Rich Fibrin (PRF)
EXPERIMENTALDiode laser
EXPERIMENTALInterventions
for the preparation of PRF, A well-trained professional nurse drew 10ml of patient blood from the antecubital vein and transferred it to a test tube without anticoagulant. The blood sample was immediately centrifuged for 10-12 minutes at 3000 rpm. L-PRF was ready to use after centrifugation. PRF membrane was put over the implant and slightly tucked under the soft tissue periphery, then held in place with a figure-of-8 suture by 0.5 proline suture
* A 980 nm diode laser device (BIOLASE) was applied in a circular motion to the blood formed at the socket orifice at a power of 1W for 1 minute with a continuous wave mode, the application was done without touching the pooling blood and with a non-activated tip of the fiber optic. * The laser application cycle was repeated 3-5 times to yield a stable fixed blood clot covering the dental implant with no oozing blood from its periphery.
Eligibility Criteria
You may qualify if:
- Any non-restorable hopeless tooth: a badly decayed tooth that cannot be restored, tooth with failed endodontic treatment, and teeth with longitudinal fracture.
- Post-extraction sockets type 1 with all bony walls intact; Type I extraction sockets according to Elian classification in 2007 have an intact labial plate of the bone and no soft tissue recession. Therefore, it does not require a mucoperiosteal flap elevation, only bone graft particles are packed into the socket after atraumatic extraction and socket debridement, then sealed with barrier membranes or soft tissue grafts.
- No signs of active periodontal disease in the selected tooth.
- Good oral hygiene
You may not qualify if:
- The presence of any systemic disease could complicate bone or soft tissue healing after immediate implant placement.
- The presence of Acute periapical infection.
- The presence of any local factor that may interfere with extraction as tooth ankyloses
- Subjects who had undergone therapeutical radiation. (187)
- Patients who had been subjected to or who were under bisphosphonate therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nourhan M.Alylead
Study Sites (1)
Faculty of Dentistry, Alexandria University
Alexandria, 21512, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Lecturer of Dental Public Health
Study Record Dates
First Submitted
August 24, 2022
First Posted
August 26, 2022
Study Start
June 10, 2021
Primary Completion
June 20, 2022
Study Completion
June 30, 2022
Last Updated
August 26, 2022
Record last verified: 2022-08